The combined endoscopic therapy (band ligation and sclerosis) in the eradication of the esophageal varices in the cirrhotic patient: Our experience;La terapia endossica combinata (legatura elastica e sclerosi) nell'eradicazione delle varici esofagee nel cirrotico. Nostra esperienza

Minerva Gastroenterologica e Dietologica

Volumn 52, Issue 3, 2006, Pages 309-316

  Urso, G ^a,b   Interlandi, D ^a   Puglisi, M ^a   Di Prima, P ^a   Bertino, G ^a   La Rosa, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b NONE   (Italy)

Author keywords

Cirrhosis; Endoscopic sclerosis; Esophageal varices

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; OCTREOTIDE; SOMATOSTATIN; TERLIPRESSIN;

ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC SURGERY; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER CIRRHOSIS; MALE; PATIENT COMPLIANCE; RISK FACTOR; TREATMENT RESPONSE;

COMBINED MODALITY THERAPY; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGOSCOPY; FEMALE; HUMANS; LIGATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REMISSION INDUCTION; SCLEROTHERAPY;

EID: 33750605593     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Pugh RNH, Murray-Lyan IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for the bleeding oesophageal varices. Br J Surg 1973;60:646-9.
2. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. N Engl J Med 1988;319:983-9.
3. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800-9.
4. Laine L, Stein C, Sharma V. Randomized comparison of ligation versus ligation plus sclerotherapy in patients with bleeding esophageal varices. Gastroenterology 1996;110:529-33.
5. Bhargava DK, Pokharna R. Endoscopic variceal ligation versus endoscopic variceal ligation and sclerotherapy: a prospective randomized study. Am J Gastroenterol 1997;92:950-3.
6. Masumoto H, Toyonaga A, Oho K, Iwao T, Tanikawa K. Ligation plus low-volume sclerotherapy for high-risk esophageal varices: comparison with ligation therapy of sclerotherapy alone. J Gastroenterol 1998;33:1-5.
7. Djurdjevic D, Janosevic S, Dapcevic B, Vukcevic V, Djordjevic D, Svorcan P et al. Combined ligation and sclerotherapy versus ligation alone for eradication of bleeding esophageal varices: a randomized and prospective trial. Endoscopy 1999;31:286-90.
8. Al Traif I, Fachartz FS, Al Jumah A, Al Johani M, al-Omair A, al-Bakr F et al. Randomized trial of ligation versus combined ligation and sclerotherapy for bleeding esophageal varices. Gastrointest Endosc 1999;50:1-6.
9. Umehara M, Onda M, Tajiri T, Toba M, Yoshida H, Yamashita K. Sclerotherapy plus ligation versus ligation for the treatment of esophageal varices: a prospective randomized study. Gastrointest Endosc 1999;50:7-12.
10. Argonz J, Kravetz D, Suarez A, Romero G, Bildozola M, Passamonti M et al. Variceal band ligation and variceal band ligation plus sclerotherapy in the prevention of recurrent variceal bleeding in cirrhotic patients: a randomized, prospective and controlled trial. Gastrointest Endosc 2000;51:157-63.
11. Cheng YS, Pan S, Lien GS, Suk FM, Wu MS, Chen JN et al. Adjuvant sclerotherapy after ligation for the treatment of esophageal varices: a prospective, randomized long-term study. Gastrointest Endosc 2001;53:566-71.
12. Hou MC, Chen WC, Lin HC, Lee FY, Chang FY, Lee SD. A new "sandwich" method of combined endoscopic variceal ligation and sclerotherapy versus ligation alone in the treatment of esophageal variceal bleeding: a randomized trial. Gastrointest Endosc 2001;53:572-8.
13. Tajiri T, Onda M, Yashida H, Mamada Y, Taniai N, Umehara M et al. Endoscopic scleroligation is a superior new technique for preventing recurrence of esophageal varices. J Nippon Med Sch 2002;69:160-4.
14. Singh P, Pooran N, Indaram A, Bank S. Combined ligation and sclerotherapy versus ligation alone for secondary phophylaxis of esophageal variceal bleeding: a meta-analysis. Am J Gastroenterol 2002;97:623-9.
15. Bohnacker S, Parupudi VJ, Soehendra N. The role of endoscopic therapy in the treatment of bleeding varices. Baillieres Clin Gastroenterol 2000;14:477-94.
16. Paquet KJ, Oberhammer E. Sclerotherapy of bleeding esophageal varices by means endoscopy. Endoscopy 1978;10:7-12.
17. Vosmik J, Jedlicka K, Mulder J, Cort JH. Action of the triglycyl hormon ogen of vasopressin (glypressin) in patients with liver cirrhosis and bleeding esophageal varices. Gastroenterology 1977;72 (4 Pt 1):605-9.
18. Bosch J, Kravetz D, Rodes J. Effects of somatostatin on hepatic and sistemic hemodynamics in patients with cirrhosis of the liver. Comparison with vasopressin. Gastroenterology 1981;80:518-25.
19. Bauer W, Briner U, Doepfnes W, Haller R, Huguenin R, Marbach P et al. SMS 201-995: A very potent and selective octapeptide analoughe of somatostatin with prolanged action. Life Sci 1982;31:1133-40.
20. Sengstaken RW, Blakemore AH. Ballon tamponade for the control of the hemmorrhage from esophageal varices. Ann Surg 1950;131:781-9.
21. Stiegman GV, Yamamoto M. Endoscopic technique for the treatment of active variceal bleebing. Gastrointest Endosc Clin N Am 1992;2:59-75.
22. Hou MC, Lin HC, Lee FY, Chang FY, Lee SD. Recurrence of esophageal varices following endoscopic treatment and its impact on rebleeding comparison of sclerotherapy and ligation. J Hepatol 2000;32:202-8.
23. Leung VKS, Sung JJY, Ahuja AT. Large paraesophageal varices on endosonography predict recurrence of esophageal varices and rebleeding. Gastroenterology 1997;112:1811-6.
24. Pascal JP, Cales P. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1987;317:856-61.
25. Propranolol for prophylaxis of bleeding in cirrhotic patients with large varices: a multicenter, randomised clinical trial. The Italian multicentric project for propranolol in prevention of bleeding. Hepatology 1988;8:1-5.
26. Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: a randomized multicenter trial. The Prova Study Group. Hepatology 1991;14:1016-24.
27. Lebrec D, Poynard T, Capron JP. Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial. J Hepatol 1988;7:118-25.
28. Ideo G, Bellati G, Fesce G, Grimoldi D. Nadolol can prevent the first gastrointestinal bleeding in cirrhotics. A prospective randomized study. Hepatology 1988;8:6-9.
29. Angelico M, Carli L, Piat C, Gentile S, Capocaccia L. Effects of isosorbide 5- mononitrato compared with propranolol on first bleeding and long-term survival in cirrhosis. Gastroenterology 1997;113:1632-9.
30. Westaby D. Improved survival following injection sclerotherapy of esophageal varices: final analysis of a controlled trial. Hepatology 1985;5:827-30.
31. Piai G, Matera D, Minieri M et al. A prospective controlled study of endoscopic oesophageal variceal sclerotherapy in advanced cirrhosis. Ital J Gastroenterol 1987;19:257-60.